Last reviewed · How we verify
Cefaloridin (cefaloridine)
Cefaloridin (generic name: cefaloridine) is a cefaloridine drug. It is currently in unknown development.
Cefaloridine works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
Cefaloridin is a small molecule, semisynthetic derivative of cephalosporin C, a type of Beta lactam antibiotic similar to penicillin. Its chemical structure consists of cephems, carboxyl groups, and a pyridinium ring.
At a glance
| Generic name | cefaloridine |
|---|---|
| Drug class | cefaloridine |
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Imagine the bacterial cell wall as a brick wall. Cefaloridine blocks the enzymes that help build the wall, causing the wall to weaken and eventually collapse, killing the bacteria. This mechanism is crucial for treating bacterial infections.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cefaloridin CI brief — competitive landscape report
- Cefaloridin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Cefaloridin
What is Cefaloridin?
How does Cefaloridin work?
What is the generic name of Cefaloridin?
What drug class is Cefaloridin in?
What development phase is Cefaloridin in?
Related
- Drug class: All cefaloridine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing